hotspot -WSS

hotspot

author：entertainment 2025-09-28 23:49:37 - browse：44

Verve Therapeutics said Sunday that the first 10 people to receive a one-time treatment powered by a form of CRISPR called base editing showed reductions in bad cholesterol levels — study results that are preliminary but signal the potential for gene-editing treatments to benefit people with an inherited type of cardiovascular disease.

Three of the study participants treated with potentially therapeutic doses of the Verve drug, called VERVE-101, showed reductions in LDL-C levels of 39%, 48%, and 55%, respectively. The latter patient’s decline in so-called “bad” cholesterol was maintained for six months.

The Verve-101 study results were presented at the American Heart Association conference and are the first data in patients from a therapy that uses base editing to change individual letters of DNA. Verve licensed the base-editing technology from Beam Therapeutics.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： EU fines Illumina $475 million over Grail acquisition

WSS

China sends large group of warplanes, navy ships towards Taiwan in forceful display

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

One Duchenne patient's bittersweet hope for new treatment

Ozempic has benefits for kidney disease as well as diabetes

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Inflation cooled significantly in June, bringing price hikes close to normal levels

focus

hotspot

hotspot

23andMe had bad news about my health. I wish a person had delivered it

For AI in health care standards, federal regulators join with industry group

Bright Health sells Medicare Advantage business to Molina

Streamlined flu vaccines recommended by FDA advisory panel

In Memoriam: Notable people who died in 2023

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

Psychedelics group wrestles with new pharma identity

Medicare drug price negotiation continues, as pharma counteroffers

How one medical school became remarkably diverse

One Duchenne patient's bittersweet hope for new treatment

leisure time

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

Grail's uphill battle for Medicare to cover its cancer screening test

Superbugs, antibiotic resistance get scrutiny in congress

How are insurers handling Leqembi and related scans?

First over

knowledge

hotspot

Wikipedia

Wikipedia